
Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.

Your AI-Trained Oncology Knowledge Connection!


Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.

Kathryn Ruddy, MD, associate professor of Oncology, Mayo Clinic, discusses the management of central nervous system (CNS) metastases in HER2-positive breast cancer.

Kathryn Ruddy, MD, discusses how genetic testing could impact treatment of patients with breast cancer.

Published: May 10th 2022 | Updated:

Published: November 6th 2018 | Updated:

Published: October 13th 2018 | Updated: